Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lichtenstein Pharmazeutica GmbH

Latest From Lichtenstein Pharmazeutica GmbH

Fournier's European Strategy

To reduce its dependence on a stagnant and price sensitive French market, Fournier has created a low-risk R&D program coupled with an aggressive international acquisition program. The program attempts to take advantage of small-market research opportunities as well as acquisition targets overlooked by large companies or which fall out of mega-mergers. Is this gamble enough to ensure independence for a mid-sized player?
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Lichtenstein Pharmazeutica GmbH
  • Senior Management
  • Contact Info
  • Lichtenstein Pharmazeutica GmbH
    83313 Bad Adelholzen/Siegsdorf
    Fürstenfeldbruck, 82256
    Germany
UsernamePublicRestriction

Register